Administration of mesenchymal stem cells and ziprasidone enhanced amelioration of ischemic brain damage in rats

Molecules and Cells

Volumn 36, Issue 6, 2013, Pages 534-541

  Kaengkan, Phatcharida ^a   Baek, Seung Eun ^a   Kim, Ji Yeong ^a   Kam, Kyung Yoon ^a   Do, Byung Rok ^b   Lee, Eun Shin ^c   Kang, Sung Goo ^a  

^a Inje University   (South Korea)

^b Bioengineering Institute Hurim Biocell Inc   (South Korea)

^c Gyeongsang National University   (South Korea)

Author keywords

Combination therapy; Ischemic brain; Mesenchymal stem cell; Ziprasidone

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR RECEPTOR; NERVE GROWTH FACTOR; ZIPRASIDONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN DAMAGE; BRAIN FUNCTION; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; MESENCHYMAL STEM CELL; MIDDLE CEREBRAL ARTERY OCCLUSION; NEURAL STEM CELL; NEUROPROTECTION; NONHUMAN; RAT; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

ANIMALIA; RATTUS;

ANIMALS; BRAIN ISCHEMIA; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELL SURVIVAL; COMBINED MODALITY THERAPY; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; HUMANS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICROGLIA; NERVE GROWTH FACTOR; NEURAL STEM CELLS; NEUROPROTECTIVE AGENTS; PIPERAZINES; RATS; RATS, SPRAGUE-DAWLEY; THIAZOLES;

EID: 84900455319     PISSN: 10168478     EISSN: 02191032     Source Type: Journal    
DOI: 10.1007/s10059-013-0235-2     Document Type: Article

References (31)

1. Bai, O., Chlan-Fourney, J., Bowen, R., Keegan, D., and Li, X.-M. (2003). Expression of brain-derived neurotrophic factor mRNA in rat hippocampus after treatment with antipsychotic drugs. J. Neurosci. Res. 71, 127-131. (Pubitemid 36008409)
2. Bliss, T., Guzman, R., Daadi, M., and Steinberg, G.K. (2007). Cell transplantation therapy for stroke. Stroke 38, 817-826. (Pubitemid 46188256)
3. Broughton, B.R.S., Reutens, D.C., and Sobey, C.G. (2009). Apoptotic mechanisms after cerebral Ischemia. Stroke 40, e331-e339.
4. Caley, C.F., and Cooper, C.K. (2002). Ziprasidone: the fifth atypical antipsychotic. Ann. Pharmacother. 36, 839-851. (Pubitemid 34517416)
5. Chen, J., Sanberg, P.R., Li, Y., Wang, L., Lu, M., Willing, A.E., Sanchez-Ramos, J., and Chopp, M. (2001). Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats. Stroke 32, 2682-2688. (Pubitemid 33055324)
6. Chen, J., Li, Y., Wang, L., Lu, M., and Chopp, M. (2002). Caspase inhibition by Z-VAD increases the survival of grafted bone marrow cells and improves functional outcome after MCAO in rats. J. Neurol. Sci. 199, 17-24. (Pubitemid 34669838)
7. Choi, D.K., Koppula, S., and Suk, K. (2011). Inhibitors of microglial neurotoxicity: focus on natural products. Molecules 16, 1021-1043.
8. Cosi, C., Waget, A., Rollet, K., Tesori, V., and Newman-Tancredi, A. (2005). Clozapine, ziprasidone and aripiprazole but not haloperidol protect against kainic acid-induced lesion of the striatum in mice, in vivo: Role of 5-HT1A receptor activation. Brain Res. 1043, 32-41. (Pubitemid 40603369)
9. Daniel, D.G., and Copeland, L.F. (2000). Ziprasidone: comprehensive overview and clinical use of a novel antipsychotic. Expert Opin. Invest. Drugs 9, 819-828. (Pubitemid 30175648)
10. De Keyser, J., Sulter, G., and Luiten, P.G. (1999a). Clinical trials with neuroprotective drugs in acute ischaemic stroke: are we doing the right thing? Trends Neurosci. 22, 535-540.
11. De Keyser, J., Sulter, G., and Luiten, P.G. (1999b). Clinical trials with neuroprotective drugs in acute ischaemic stroke: are we doing the right thing? Trends Neurosci. 22, 535-540.
12. Dirnagl, U., Iadecola, C., and Moskowitz, M.A. (1999). Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 22, 391-397. (Pubitemid 29453643)
13. Hong, I.K., Jeong, N.H., Kim, J.R., Do, B.-R., Kim, H.K., and Kang, S.G. (2008). Differentiation of dopaminergic and cholinergic neurons from mesenchymal-like stem cells derived from the adipose tissue. Dev. Reprod. 12, 31-39.
14. Hoogduijn, M.J., Popp, F., Verbeek, R., Masoodi, M., Nicolaou, A., Baan, C., and Dahlke, M.-H. (2010). The immunomodulatory properties of mesenchymal stem cells and their use for immunotherapy. Int. Immunopharmacol. 10, 1496-1500.
15. Kaengkan, P., Baek, S.E., Choi, Y.W., Kam, K.-Y., Kim, J.Y., Wu, Y.R., Do, B.-R., and Kang, S.G. (2013). Combination effect of phydroxybenzyl alcohol and mesenchymal stem cells on the recovery of brain damage in a rat model of brain ischemia. Animal Cell. Syst. 17, 160-169.
16. Kam, K.-Y., Jalin, A.M.A., Choi, Y.W., Kaengkan, P., Park, S.W., Kim, Y.H., and Kang, S.G. (2012). Ziprasidone attenuates brain injury after focal cerebral ischemia induced by middle cerebral artery occlusion in rats. Prog. Neuropsychopharmacol. Biol. Psychiatry 39, 69-74.
17. Lauterbach, E.C., Shillcutt, S.D., Victoroff, J., Coburn, K.L., and Mendez, M.F. (2010). Psychopharmacological neuroprotection in neurodegenerative disease: heuristic clinical applications. J. Neuropsychiatry Clin. Neurosci. 22, 130-154.
18. Liu, B., and Hong, J.S. (2003). Role of microglia in inflammation- mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention. J. Pharmacol. Exp. Ther. 304, 1-7. (Pubitemid 36008905)
19. Longa, E.Z., Weinstein, P.R., Carlson, S., and Cummins, R. (1989). Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20, 84-91. (Pubitemid 19040218)
20. Mauri, M., Lentini, D., Gravati, M., Foudah, D., Biella, G., Costa, B., Toselli, M., Parenti, M., and Coco, S. (2012). Mesenchymal stem cells enhance GABAergic transmission in co-cultured hippocampal neurons. Mol. Cell. Neurosci. 49, 395-405.
21. Nemeroff, C.B., Lieberman, J.A., Weiden, P.J., Harvey, P.D., Newcomer, J.W., Schatzberg, A.F., Kilts, C.D., and Daniel, D.G. (2005). From clinical research to clinical practice: a 4-year review of ziprasidone. CNS Spectr. 10, 1-20.
22. Pandya, R.S., Mao, L., Zhou, H., Zhou, S., Zeng, J., Popp, A.J., and Wang, X. (2011). Central nervous system agents for ischemic stroke: neuroprotection mechanisms. Cent. Nerv. Syst. Agents Med. Chem. 11, 81-97.
23. Paxinos, G., and Watson, C. (2007). The Rat Brain in Stereotaxic Coordinates (Academic Press).
24. Rosa, A.R., Franco, C., Torrent, C., Comes, M., Cruz, N., Horga, G., Benabarre, A., and Vieta, E. (2008). Ziprasidone in the treatment of affective disorders: a review. CNS Neurosci. Therapeutics 14, 278-286.
25. Savitz, S.I., Rosenbaum, D.M., Dinsmore, J.H., Wechsler, L.R., and Caplan, L.R. (2002). Cell transplantation for stroke. Ann. Neurol. 52, 266-275. (Pubitemid 35001492)
26. Seeger, T.F., Seymour, P.A., Schmidt, A.W., Zorn, S.H., Schulz, D.W., Lebel, L.A., McLean, S., Guanowsky, V., Howard, H.R., and Lowe, J.A. (1995). Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activity. J. Pharmacol. Exp. Ther. 275, 101-113.
27. Suda, S., Shimazaki, K., Ueda, M., Inaba, T., Kamiya, N., Katsura, K.-i., and Katayama, Y. (2011). Combination therapy with bone marrow stromal cells and FK506 enhanced amelioration of ischemic brain damage in rats. Life Sci. 89, 50-56.
28. Takahashi, K., Yasuhara, T., Shingo, T., Muraoka, K., Kameda, M., Takeuchi, A., Yano, A., Kurozumi, K., Agari, T., Miyoshi, Y., et al. (2008). Embryonic neural stem cells transplanted in middle cerebral artery occlusion model of rats demonstrated potent therapeutic effects, compared to adult neural stem cells. Brain Res. 1234, 172-182.
29. Terry, A.V., Parikh, V., Gearhart, D.A., Pillai, A., Hohnadel, E., Warner, S., Nasrallah, H.A., and Mahadik, S.P. (2006). Time-dependent effects of haloperidol and ziprasidone on nerve growth factor, cholinergic neurons, and spatial learning in rats. J. Pharmacol. Exp. Ther. 318, 709-724. (Pubitemid 44061246)
30. Woodbury, D., Schwarz, E.J., Prockop, D.J., and Black, I.B. (2000). Adult rat and human bone marrow stromal cells differentiate into neurons. J. Neurosci. Res. 61, 364-370. (Pubitemid 30620221)
31. Zhao, Y., Guan, Y., Xu, Y., Li, Y., and Wu, W. (2012). Sodium Ferulate combined with bone marrow stromal cell treatment ameliorating rat brain ischemic injury after stroke. Brain Res. 1450, 157-165.